Vernalis plc
Vernalis plc is a British company specializing in the development of pharmaceutical products. It is a subsidiary of Ligand Pharmaceuticals, an American company. Vernalis was originally established in 1988 as Vanguard Medica, and it was rebranded as Vernalis in 2002. The company's primary focus is on the development of products for the treatment of neurological disorders and cancer.
History[edit | edit source]
Vernalis plc was founded in 1988 as Vanguard Medica by Dr. Peter Bains. The company initially focused on the development of drugs for migraine and Parkinson's disease. In 2002, the company was rebranded as Vernalis following a merger with British Biotech.
In 2018, Vernalis was acquired by Ligand Pharmaceuticals, an American biopharmaceutical company. Following the acquisition, Vernalis continues to operate as a subsidiary of Ligand, focusing on the discovery and development of novel pharmaceutical products.
Products[edit | edit source]
Vernalis has developed several pharmaceutical products, including Frovatriptan for the treatment of migraine, and Apomorphine for the treatment of Parkinson's disease. The company also has several products in various stages of clinical development, including treatments for cancer, inflammatory diseases, and respiratory diseases.
Research and Development[edit | edit source]
Vernalis's research and development efforts are focused on the discovery and development of novel pharmaceutical products. The company utilizes a range of technologies, including structure-based drug design, to develop its products. Vernalis's research and development activities are primarily conducted at its facilities in the United Kingdom.
See Also[edit | edit source]
- Ligand Pharmaceuticals
- Pharmaceutical industry in the United Kingdom
- List of pharmaceutical companies
References[edit | edit source]
External Links[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
